| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VPH.2012.01.009 |
| P698 | PubMed publication ID | 22329947 |
| P50 | author | Ziad Mallat | Q45827826 |
| Alain Tedgui | Q57298641 | ||
| P2093 | author name string | Emily A Van Vré | |
| Padmapriya Ponnuswamy | |||
| P2860 | cites work | A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 |
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 | ||
| Th17 and regulatory T cells in mediating and restraining inflammation | Q27687428 | ||
| B1 cells: similarities and differences with other B cell subsets | Q28202678 | ||
| T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt | Q28589692 | ||
| CD1 recognition by mouse NK1+ T lymphocytes | Q28591238 | ||
| Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease | Q78628965 | ||
| Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6 | Q78870882 | ||
| Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis | Q79711302 | ||
| B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations | Q80227241 | ||
| Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? | Q80908056 | ||
| Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage | Q81098943 | ||
| Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury | Q81332625 | ||
| Flt3 signaling-dependent dendritic cells protect against atherosclerosis | Q82480465 | ||
| Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability | Q82663771 | ||
| Downregulation of T helper cell type 3 in patients with acute coronary syndrome | Q84240443 | ||
| Anti-endothelial cell antibodies are increased in patients with previous myocardial infarction | Q84363836 | ||
| The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice | Q84738724 | ||
| Type I natural killer T cells: naturally born for fighting | Q37728011 | ||
| Interleukin-17: friend or foe in atherosclerosis? | Q37777607 | ||
| B-lymphocyte effector functions in health and disease | Q37815038 | ||
| Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity | Q37830940 | ||
| IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice | Q37852203 | ||
| Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets | Q37866627 | ||
| Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques | Q37942858 | ||
| Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 | ||
| IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation | Q39496836 | ||
| Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis | Q39634192 | ||
| Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. | Q39975880 | ||
| Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development | Q40126964 | ||
| Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages | Q40943525 | ||
| GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels | Q41649746 | ||
| Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells | Q41712990 | ||
| Induction of T-cell activation by oxidized low density lipoprotein | Q41940298 | ||
| Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma | Q42162162 | ||
| Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice | Q42757050 | ||
| A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice | Q42856694 | ||
| Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. | Q43247649 | ||
| Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice | Q43455128 | ||
| Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. | Q43518318 | ||
| T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia | Q43624009 | ||
| Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
| IL-33 reduces the development of atherosclerosis | Q28594104 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
| 2. Cytokines and chemokines | Q30310536 | ||
| B-cell aortic homing and atheroprotection depend on Id3. | Q30422974 | ||
| Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice | Q30432644 | ||
| IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor | Q30439191 | ||
| Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent | Q30440410 | ||
| Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. | Q30481584 | ||
| Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. | Q31807209 | ||
| Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions | Q33294845 | ||
| Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice | Q33314514 | ||
| Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice | Q33399367 | ||
| Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile | Q33656103 | ||
| The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation | Q33784558 | ||
| T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
| Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis | Q33839918 | ||
| Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells | Q33967700 | ||
| B cell depletion reduces the development of atherosclerosis in mice | Q34044387 | ||
| Regulatory B cells: evidence, developmental origin and population diversity | Q34143986 | ||
| The double life of a B-1 cell: self-reactivity selects for protective effector functions | Q34154602 | ||
| The immune system in atherosclerosis | Q34164644 | ||
| T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
| Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice | Q34411828 | ||
| Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome | Q34427494 | ||
| Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions | Q34457373 | ||
| Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 | ||
| The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) mice | Q34644753 | ||
| Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction | Q34766788 | ||
| A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses | Q34778834 | ||
| Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice | Q34789613 | ||
| Role of heat shock proteins in atherosclerosis | Q34960748 | ||
| Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. | Q43794492 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study | Q43846699 | ||
| Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice | Q43909351 | ||
| The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status | Q43935715 | ||
| B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice | Q44212443 | ||
| Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice | Q44545474 | ||
| The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia | Q44967545 | ||
| Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice. | Q45979840 | ||
| Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events | Q46125332 | ||
| B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions | Q46365271 | ||
| High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction | Q46457217 | ||
| Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions | Q46711267 | ||
| Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice | Q46874178 | ||
| Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice | Q47392093 | ||
| Natural killer T cells accelerate atherogenesis in mice | Q47685326 | ||
| Requirement for CD154 in the progression of atherosclerosis. | Q52536870 | ||
| Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. | Q52595013 | ||
| Inhibition of IL-17A in atherosclerosis. | Q53080293 | ||
| Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. | Q53244567 | ||
| Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. | Q53258982 | ||
| Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. | Q53362260 | ||
| Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. | Q53370200 | ||
| Effect of natural killer T cell activation on the initiation of atherosclerosis. | Q53379699 | ||
| The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. | Q53551964 | ||
| Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. | Q53591262 | ||
| Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. | Q53591929 | ||
| Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women. | Q53669196 | ||
| Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. | Q54412663 | ||
| Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. | Q54463267 | ||
| Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes | Q56901831 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability | Q58150092 | ||
| Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines | Q60746676 | ||
| Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice | Q62735590 | ||
| Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient Mice | Q63363313 | ||
| An immunohistochemical analysis of human aortic fatty streaks | Q68943921 | ||
| Variation in susceptibility to atherosclerosis among inbred strains of mice | Q69805944 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis | Q72209255 | ||
| Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 | ||
| Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction | Q73965948 | ||
| Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation | Q74144043 | ||
| The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice | Q74598506 | ||
| Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women | Q74839800 | ||
| Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice | Q77995417 | ||
| Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice | Q35103567 | ||
| Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia | Q35133174 | ||
| IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice | Q35187080 | ||
| Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice | Q35187089 | ||
| The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. | Q35484658 | ||
| Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment | Q35552966 | ||
| Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells | Q35566640 | ||
| CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice | Q35572404 | ||
| Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
| Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65 | Q35611112 | ||
| Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity | Q35613674 | ||
| Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis | Q35781343 | ||
| The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
| Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice | Q36202916 | ||
| Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population | Q36368203 | ||
| Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells | Q36376543 | ||
| CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
| Disruption of TGF-β signaling in T cells accelerates atherosclerosis | Q36524547 | ||
| Invariant natural killer T cells: bridging innate and adaptive immunity | Q36739848 | ||
| Regulatory T-cell immunity in atherosclerosis | Q36812076 | ||
| CD40 and its ligand in atherosclerosis. | Q36812081 | ||
| IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis | Q36849075 | ||
| Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. | Q37109070 | ||
| Regulatory T-cell immunity and its relevance to atherosclerosis | Q37138025 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis | Q37377439 | ||
| Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice | Q37385727 | ||
| The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis | Q37414502 | ||
| Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium | Q37472019 | ||
| Macrophage diversity and polarization in atherosclerosis: a question of balance | Q37583322 | ||
| Review of human DC subtypes | Q37639217 | ||
| Raising the NKT cell family | Q37688877 | ||
| B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer | Q37690373 | ||
| P433 | issue | 5-6 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 193-203 | |
| P577 | publication date | 2012-02-08 | |
| P1433 | published in | Vascular Pharmacology | Q7916446 |
| P1476 | title | Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells | |
| P478 | volume | 56 |
| Q33829848 | Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells |
| Q30252928 | B cells and atherosclerosis. |
| Q38745362 | Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis |
| Q38851472 | Immune-mediated mechanisms of atherosclerosis and implications for the clinic |
| Q38213957 | Multiple roles of connexins in atherosclerosis- and restenosis-induced vascular remodelling. |
| Q93068776 | NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co-expression network analysis |
| Q38059631 | Neuroimmunology of the atherosclerotic plaque: a morphological approach |
| Q36291435 | Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation |
| Q35907898 | Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment |
| Q38562438 | T- and B-cell subsets in periodontitis |
Search more.